Novus Therapeutics, Inc (NVUS) PT Lowered to $3.25 at Ascendiant Capital
Tweet
Share
E-mailGet Alerts NVUS Hot Sheet
Price: $14.60 --0%
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Ascendiant Capital analyst Edward Woo lowered the price target on Novus Therapeutics, Inc (NASDAQ: NVUS) to $3.25 (from $3.50) while maintaining a Buy rating.
You May Also Be Interested In
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- Legence Corp (LGN) PT Lowered to $100 at BTIG
- Tingyi Cayman Islands Holding Corp. (322:HK) (TCYMY) PT Raised to HK$11.60 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
